On June 3, 2019 CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, reported that it will be presenting at the 9th annual LD Micro Invitational on Tuesday, June 4th at 10:40 a.m. PT. Geert Kersten, Chief Executive Officer of CEL-SCI, will be giving the presentation (Press release, Cel-Sci, JUN 3, 2019, View Source [SID1234536837]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Kersten’s presentation will be webcast and available in the Investor Relations section of the Company’s website at View Source The webcast will be archived for 90 days following the presentation.

The conference will be held at the Luxe Sunset Boulevard Hotel in Los Angeles, California, will feature 250 companies in the small-cap / micro-cap space, and will be attended by over 1,000 individuals.